Nanosized sustained-release pyridostigmine bromide microcapsules: process optimization and evaluation of characteristics

BACKGROUND: Pyridostigmine bromide (3-[[(dimethylamino)-carbonyl]oxy]-1-methylpyridinium bromide), a reversible inhibitor of cholinesterase, is given orally in tablet form, and a treatment schedule of multiple daily doses is recommended for adult patients. Nanotechnology was used in this study to de...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Qunyou, Jiang, Rong, Xu, Meiling, Liu, Guodong, Li, Songlin, Zhang, Jingqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582480/
https://www.ncbi.nlm.nih.gov/pubmed/23459707
http://dx.doi.org/10.2147/IJN.S40860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582480/
https://www.ncbi.nlm.nih.gov/pubmed/23459707
http://dx.doi.org/10.2147/IJN.S40860

Ejemplares similares